Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.

It's uncertain whether the Biden administration proposal to cover obesity drugs in Medicare and Medicaid will survive ...

The market didn't appreciate Amgen 's ( AMGN 1.00%) latest clinical data update, with the biopharma's shares falling more ...

钛媒体App ...

The outgoing Biden administration is proposing to have popular weight-loss drugs like Wegovy or Zepbound covered by Medicare ...

This is a prescription medication originally used for diabetes but now approved for weight loss. Most people regained weight ...

分析人士指出，这与礼来的Zepbound的最高剂量效果相当。但Ze... 11月27日｜安进公司周二公布，在为期一年的试验中，非糖尿病患者每月或更少频次 ...

尽管安进公司的MariTide减肥药疗效符合预期，但由于副作用较高且未超过礼来公司的Zepbound，且试验结果低于华尔街高预期，导致安进股价周二一度 ...

【11 月 27 日，安进公司公布减肥药 MariTide 试验结果】在为期一年的试验中，非糖尿病患者每月或更少频次服用一次 MariTide，最多减轻 20%体重。 分析人士指出，其效果与礼来的 Zepbound 最高剂量相当，但 Zepbound ...

My husband and I have started taking Zepbound for various medical reasons. The medication has significantly and positively ...

分析人士指出，这与礼来的Zepbound的最高剂量效果相当。然而，数据显示MariTide的副作用比Zepbound更大，约11%的患者因副作用退出了MariTide试验 ...

格隆汇11月27日｜安进 ...